Clinical Researcher; Psychosis Research

This is an exciting opportunity to play a leading role in a Wellcome funded clinical trial “FOCUS: Function and Cognition in Early Psychosis”.  The FOCUS trial will investigate the effects of xanomeline-trospium compared to standard dopamine blocking therapies on cognitive function in individuals with early psychosis. In addition, the integration of comprehensive neuroimaging batteries will provide the opportunity for insights regarding both the pathophysiology of psychosis, and mechanisms of treatment.  The post is full time and is based in the Department of Psychiatry at the Warneford Hospital, Oxford.

The post is fixed-term (funded for 12 months from August 2024) in the first instance.

Reporting to Dr Rob McCutcheon, you will join a group of researchers with wide-ranging expertise, and a belief there is an opportunity to make fundamental advances in the treatment of psychotic disorders, thereby improving the outcomes for individuals with psychosis.  You will have the opportunity to undertake analyses of neuroimaging measures and cognitive outcomes, the development of clinical services, the conducting of meta-analyses, and the analysis of pre-acquired clinical trial data.  The post would suit a candidate interested in going on to further research (DPhil/DM).

You will have a medical degree and GMC registration, along with experience of working with individuals with psychotic disorders. Experience in neuroimaging and recruiting individuals with psychotic disorders to research studies would be desirable.

The closing date for the posts is 12.00 midday on 24th April 2024.

You will be required to upload a covering letter/supporting statement and a CV as part of your application.